Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Transfusion ; 56 Suppl 2: S128-39, 2016 04.
Artigo em Inglês | MEDLINE | ID: mdl-27100749

RESUMO

The early transfusion of plasma is important to ensure optimal survival of patients with traumatic hemorrhage. In military and remote or austere civilian settings, it may be impossible to move patients to hospital facilities within the first few hours of injury. A dried plasma product with reduced logistical requirements is needed to enable plasma transfusion where medically needed, instead of only where freezers and other equipment are available. First developed in the 1930s, pooled lyophilized plasma was widely used by British and American forces in WWII and the Korean War. Historical dried plasma products solved the logistical problem but were abandoned because of disease transmission. Modern methods to improve blood safety have made it possible to produce safe and effective dried plasma. Dried plasma products are available in France, Germany, South Africa, and a limited number of other countries. However, no product is available in the US. Promising products are in development that employ different methods of drying, pathogen reduction, pooling, packaging, and other approaches. Although challenges exist, the in vitro and in vivo data suggest that these products have great potential to be safe and effective. The history, state of the science, and recent developments in dried plasma are reviewed.


Assuntos
Transfusão de Sangue/métodos , Plasma , Transfusão de Componentes Sanguíneos/métodos , Segurança do Sangue/métodos , Liofilização , Humanos
2.
Mil Med ; 170(1): 63-9, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15724857

RESUMO

Uncontrolled hemorrhage is the leading cause of preventable combat-related deaths. The vast majority of these deaths occur in the field before the injured can be transported to a treatment facility. Early control of hemorrhage remains the most effective strategy for treating combat casualties. A number of hemostatic agents have recently been deployed to the warfront that can be used to arrest bleeding before surgical control of the source. The purpose of this article is to summarize the background information regarding these hemostatic agents, indications and rationale for their use, and characteristics of these products that may impact effectiveness.


Assuntos
Hemorragia/tratamento farmacológico , Hemostáticos/uso terapêutico , Medicina Militar/métodos , Guerra , Ferimentos e Lesões/fisiopatologia , Acetilglucosamina/uso terapêutico , Coagulação Sanguínea/efeitos dos fármacos , Adesivo Tecidual de Fibrina/uso terapêutico , Hemorragia/prevenção & controle , Hemostáticos/classificação , Humanos , Zeolitas/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...